Nanotechnology Now

Our NanoNews Digest Sponsors

Heifer International

Wikipedia Affiliate Button

Home > Press > Medtech Insight and Windhover Information’s Upcoming ''Investment In Innovation (In3) West'' Conference Featuring 54 Early- to Late-Stage Device Compa

Abstract:
Medtech Insight, a division of Windhover Information, Inc. and a leading provider of business information for the medical device industry, has announced that >50 promising early- to late-stage medical device companies seeking funding and/or strategic partnership are currently confirmed to present at its "Investment In Innovation (In3) West" conference, being held February 27-29 at The Venetian Resort-Hotel-Casino in Las Vegas, Nevada. The two-day In3 West event (www.windhover.com/in3west08) - the company's 29th In3 conference - will showcase a carefully selected group of innovative young medtech companies from around the world presenting (the majority for the first time on our stage) to an audience of 250+ senior business development and investment executives from the leading medical technology and healthcare investment firms from around the world, for purposes of raising funding or forming strategic partnerships.

Medtech Insight and Windhover Information’s Upcoming ''Investment In Innovation (In3) West'' Conference Featuring 54 Early- to Late-Stage Device Compa

NEWPORT BEACH, CA | Posted on February 12th, 2008

Presentations from this group of cutting-edge, early- to late-stage companies will encompass a wide variety of high-growth device sectors, including cardiovascular therapeutics and diagnostics/interventional cardiology, diagnostics, drug delivery, imaging, minimally invasive surgery, nanotechnology, neurostimulation, oncology, orthopedics/spine, peripheral vascular, stem cells, stroke management, tissue engineering, and wound management, to mention only a few. The nearly-full program of presenters confirmed to date include: Advanced Headache Intervention, Angel Medical Systems, Ascension Technology, BioTelligent, Bone Biologics, Cardiac Output Technologies, Ceragenix Pharmaceuticals, Cohera Medical, CoreSpine Technologies, Crospon, CVAC Systems, Deca-Medics, eCardio Diagnostics, EMKinetics, HealthLink Europe, HemoBioTech, Infrared Sciences, Innovent Medical Solutions, Intellwave, Interventional and Surgical Innovations (presenting 4 technologies), Light Sciences Oncology, Med-Conduit, Micronics, Minnow Medical, mNemoscience, Moerae Matrix, Navigant Biotechnologies, Neomend, Nerites, Nesos Health, Novian Health, Ortho Kinematics, Photo Dynamic Therapy, PolyRemedy, Portland Orthopaedic, Praxim, Provista Life Sciences, Seno Medical Instruments, STI Medical Systems, Sunshine Heart Company, ThermopeutiX, Tissue Genetics, Ultimate Spine, ValveXchange, VeinAid, Veran Medical, Victhom Human Bionics, Visualase, Vivoxid, Xylos Corporation, and Zassi Medical Evolutions.

The In3 West format will include focused 10-minute presentations by a senior executive from each presenting company to our full audience, each followed immediately by one-on-one meetings with interested parties in private breakout rooms. The event will also feature a presenting company product exhibition/networking reception, a Buyers' Perspective panel discussion/case study titled "What Are Buyers Looking for in 2008?", a Venture Perspective panel discussion/case study, "Doing Innovative or Unconventional Deals," a workshop presented by Christopher Velis of Medical Capital Advisors entitled "10 Things Every Medical Technology Entrepreneur Should Know," and much more.

Event co-sponsors include AdvaMed, Battelle, Boston Healthcare Associates, Business Wire, Curran International, MDMA, Medmarc and The Hartford, Medical Capital Advisors, The MedTech Group, Ronald Trahan Associates, and TATRC (financial contributor).

The growing In3 West attendee list includes a robust line-up of buy-side/investors. A sample of companies sending their teams include: 3M, Abbott Laboratories, Abbott Vascular, Aberdare Ventures, Advanced Technology Ventures, AstraZeneca Pharmaceuticals LP, Aubrey Group, Baird Venture Partners, Baxter Healthcare Corporation, Becton Dickinson & Co., Boston Scientific Corporation, Cardinal Health, Cargill Ventures, CMEA Ventures, Cook, C.R. Bard, Inc., Clarus Ventures, Edwards Lifesciences, Ethicon, Ethicon Endo-Surgery, Inc., ev3 Inc., Frazier Healthcare Ventures, Galen, Galleon Group, Hercules Technology Growth Capital, InterWest Partners, Johnson & Johnson Development Corp., Kimberly-Clark Health Care, Kobayashi Pharmaceuticals of America, Longitude Capital, Medtronic, MedVenture Technology Corporation, Musculoskeletal Transplant Foundation, Numenor Ventures LLC, OCTANe, Olympus Medical, Pharos Capital Group, Prism Venture Partners, Prospect Venture Partners, Queensland BioCapital Funds, Sante Ventures, Silicon Valley Bank, Special Situations Life Sciences Fund, Stryker, SV Life Sciences, SVB Capital, Synergy Life Science Partners, Synthes Spine, Teijin America, Teijin Pharma, Ltd., Teleflex, The Integra Group, Third Rock Ventures, Thoratec, Trevi Health Ventures, Triathlon Medical Ventures, Venrock Associates, and Western Technology Investment, among many others.

Medtech Insight and its parent company, Windhover Information, have established a reputation as holding the premier forums worldwide for discerning senior executives in the medical device, diagnostics, biotech, and pharmaceutical business development and investment communities to meet and screen promising early-stage life sciences companies in need of funding, acquisition and/or strategic partnership, and to network with key decision makers in the industry. Over 1300 emerging medical technology company presenters and over 7000 attendees have participated at In3 events over the past 7 years.

Visit www.medtechinsight.com/pastpresenters.html for a full list of previous Medtech Insight conference presenters and their technology descriptions. To read what past attendees and industry experts think of Medtech Insight's investment and partnering events, please visit www.medtechinsight.com/in3success.html.

The company's Spring 2008 "Investment In Innovation" event -- In3 Europe -- will take place in Paris, France at the Hilton Paris, April 29-30. Visit www.windhover.com/in3europe08 for regularly updated information on this exciting international event.

####

About Medtech Insight
Medtech Insight, a division of Windhover Information Inc., is the leading provider of business information and market intelligence for the medical technology marketplace.

For more information, please click here

Contacts:
Medtech Insight, a division of Windhover Information Inc.
Kristy Grimes
480-985-9512
or 888-202-5939 toll-free in the U.S.

www.medtechinsight.com
www.windhover.com

Copyright © Business Wire 2008

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

News and information

Northwestern researchers achieve unprecedented control of polymer grids: Materials could find applications in water purification, solar energy storage, body armor June 22nd, 2018

Nanobiotix Publishes Positive Phase 2/3 Data For Nanomedicine in Soft Tissue Cancer (Webcast June 22) June 22nd, 2018

Alzheimer's breakthrough: Brain metals that may drive disease progression revealed: In brains affected by Alzheimer's, researchers identify chemically reduced iron species, with mineral forms including a magnetic iron oxide June 22nd, 2018

Collaboration yields discovery of 12-sided silica cages June 20th, 2018

VC/Funding/Angel financing/Loans/Leases/Crowdfunding

180 Degree Capital Corp. to Provide Live Remote Access to Its Annual Meeting of Shareholders on June 12, 2018 June 12th, 2018

180 Degree Capital Corp. Reports Net Asset Value per Share of $2.60 as of December 31, 2017; A Decrease of 3.0% From Prior Quarter and an Increase of 11.1% From December 31, 2016 February 27th, 2018

Nanowire LED Innovator Aledia Announces €30 ($36M) Million Series-C Financing: Intel Capital Joins Existing Investors to Commercialize Certain Nanowire-LED Technologies for Mobile Displays January 29th, 2018

180 Degree Capital Corp. Leads Investment in TheStreet, Inc.; Investment Enables Removal of Capital Structure Overhang November 14th, 2017

Investments/IPO's/Splits

180 Degree Capital Corp. to Provide Live Remote Access to Its Annual Meeting of Shareholders on June 12, 2018 June 12th, 2018

Nanometrics Updates Time of Webcast at Stifel 2018 Cross Sector Insight Conference June 12th, 2018

Arrowhead Pharmaceuticals to Present at Upcoming June 2018 Conferences May 31st, 2018

Arrowhead Pharmaceuticals Reports Inducement Grants under NASDAQ Marketplace Rule 5635(c)(4) March 20th, 2018

Nanomedicine

Nanobiotix Publishes Positive Phase 2/3 Data For Nanomedicine in Soft Tissue Cancer (Webcast June 22) June 22nd, 2018

Alzheimer's breakthrough: Brain metals that may drive disease progression revealed: In brains affected by Alzheimer's, researchers identify chemically reduced iron species, with mineral forms including a magnetic iron oxide June 22nd, 2018

Collaboration yields discovery of 12-sided silica cages June 20th, 2018

JPK talks with Dr Frank Lafont, Director of the BioImaging Center Lille (BICeL) about the use of the NanoWizard® AFM together with fluorescence microscopy in the study of living cells June 19th, 2018

Announcements

Northwestern researchers achieve unprecedented control of polymer grids: Materials could find applications in water purification, solar energy storage, body armor June 22nd, 2018

Nanobiotix Publishes Positive Phase 2/3 Data For Nanomedicine in Soft Tissue Cancer (Webcast June 22) June 22nd, 2018

Alzheimer's breakthrough: Brain metals that may drive disease progression revealed: In brains affected by Alzheimer's, researchers identify chemically reduced iron species, with mineral forms including a magnetic iron oxide June 22nd, 2018

Collaboration yields discovery of 12-sided silica cages June 20th, 2018

Events/Classes

Nanobiotix Publishes Positive Phase 2/3 Data For Nanomedicine in Soft Tissue Cancer (Webcast June 22) June 22nd, 2018

Executives Explore Key Megatrends and Innovations in MEMS, Sensors, Imaging Tech at SEMI-MSIG European Summits: Speakers to share developments in smart automotive, smart cities, smart industrial, biomedical, consumer and IoT, September 19-21, 2018 in Grenoble, France June 19th, 2018

Leti Presenting Strategic Vision and Hosting a Workshop at SEMICON West: “From Electrons to Photons” Leti Workshop and CEO Media Briefing Set for Tuesday, July 10 in W Hotel, San Francisco June 12th, 2018

180 Degree Capital Corp. to Provide Live Remote Access to Its Annual Meeting of Shareholders on June 12, 2018 June 12th, 2018

NanoNews-Digest
The latest news from around the world, FREE



  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More











ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project